Ban on Oxytocin Formulations to come into effect from July 01, 2018

Jun 27, 2018 | by Avantis RegTech Legal Research Team


The Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations for domestic use to public sector only from July 01, 2018. It has also banned the import of Oxytocin and its formulations.

From July 01, 2018, no private manufacturer will be allowed to manufacture the drug for domestic use. Only Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL), a public sector company, would be manufacturing this drug for domestic use from that date. The Oxytocin formulations meant for domestic consumption will be supplied by the manufacturer, that is KAPL, to the registered hospitals and clinics in public and private sector directly. Oxytocin in any form or name will not be allowed to be sold through retail Chemist.

All the registered hospitals and clinics in public and private sector in the country are advised to contact KAPL and place their orders with the company as the drug will not be available with retail chemists or any other manufacturer.

[Release ID: 1536659]

URL: http://www.pib.nic.in/PressReleseDetail.aspx?PRID=1536659


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.